Skip to content
Screener

Baxter International BAX Investing Cash Flow

Investing Cash Flow at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
-$241M+28.3%
Stryker logo
StrykerSYK
-$639M-514%
KORU Medical Systems logo
KORU Medical SystemsKRMD
-$577.37K-1,904%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
-$90M-13.6%
Axogen logo
AxogenAXGN
-$15.96M-1,292%
ICU Medical logo
ICU MedicalICUI
-$20.14M-111%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$14.13B+22.3%
Enterprise value$12.33B+22.1%
P/S1.3×+0.2×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Baxter International’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:50 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028962
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Other investing activities, net4(2)
Cash flows from (used in) investing activities - continuing operations(133)(124)
Cash flows from (used in) investing activities - discontinued operations3,389
Cash flows from (used in) investing activities(133)3,265
Cash flows from financing activities
Repayments of debt(2,825)
Repayments of debt with original maturities of three months or less(300)
Cash dividends on common stock(5)(87)

Item 1. Financial Statements (unaudited)

FAQ

What is Baxter International's investing cash flow?
Baxter International (BAX) reported investing cash flow of -$133M in Q1 2026.
How has Baxter International's investing cash flow changed year-over-year?
Baxter International's investing cash flow decreased by 104.1% year-over-year, from $3.27B to -$133M.
What is the long-term trend for Baxter International's investing cash flow?
Over 3 years (2021 to 2024), Baxter International's investing cash flow has grown at a -61.8% compound annual growth rate (CAGR), from -$11.2B to -$626M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Baxter International's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude